# Tristel Reports 10% Revenue Growth and Higher Annual Profit for FY26

- URL: https://stocks.freetheai.org/news/tristel-reports-10-revenue-growth-and-higher-annual-profit-for-fy26-d590ae
- Published: 2026-10-19T06:00:06Z
- Category: earnings; sentiment: bullish; impact: medium
- Symbols: [LSE:TSTL](https://stocks.freetheai.org/symbols/LSE-TSTL)
- Written by our AI from expert market sources across the web for FreeTheAI Stocks, built by Vibhek Soni
- How write-ups are made: https://stocks.freetheai.org/how-we-write
- Not financial advice: https://stocks.freetheai.org/disclaimer

Infection prevention product maker Tristel plc (LSE:TSTL) reported a 10% rise in revenue to £51.1 million for the fiscal year ended June 30, 2026, up from £46.5 million in the previous year. Statutory pre-tax profit grew to £11.0 million, compared with £8.4 million a year earlier, while adjusted pre-tax profit climbed 15% to £11.7 million. The company closed the financial year debt free with £16.0 million in cash and short-term investments.

The company's core sales were anchored by its proprietary chlorine dioxide medical device decontamination chemistry, which generated 88% of overall revenue, alongside its surface disinfection range representing 9%. Performance was bolstered by operational milestones, including completing the transition to internal manufacturing for its wipe products and maintaining adjusted earnings margins above its target of 25%. Tristel also saw executive leadership changes, with Anna Wasyl becoming Chief Financial Officer in September 2025 and Chris Lee stepping in as Chief Executive Officer in August 2026.

Looking ahead, Tristel is focusing on expanding its commercial footprint in North America following regulatory clearances for its ultrasound and ophthalmic products. The company also launched its 3T Pro digital compliance platform after the period ended, introducing a premium paid tier aimed at establishing recurring digital revenue streams.

## Key points

- Full-year revenue increased 10% to £51.1 million for the year ended June 30, 2026, up from £46.5 million in 2025.
- Adjusted profit before tax rose 15% to £11.7 million, while statutory profit before tax reached £11.0 million.
- Tristel closed the period debt free with £16.0 million in cash and short-term investment balances.
- Commercial focus moves toward growing adoption in North America and scaling the newly launched 3T Pro digital platform.

## Questions and answers

### What were Tristel PLC's full-year financial results for FY2026?

Tristel PLC reported full-year revenue of £51.1 million, up 10% from £46.5 million in 2025. Statutory profit before tax rose to £11.0 million, while adjusted profit before tax grew 15% to £11.7 million.

### How much cash does Tristel PLC have and do they have debt?

Tristel ended the fiscal year on June 30, 2026, with no bank debt and £16.0 million in cash and short-term investment balances.

### What are Tristel's primary key growth drivers following FY2026?

Tristel is focusing on commercial adoption across healthcare systems in North America and monetizing its 3T Pro digital platform to generate recurring subscription revenues.